Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2014 Mar 12;73(5):991–997. doi: 10.1007/s00280-014-2432-x

Figure 1.

Figure 1

Plasma concentration-time profile of atrasentan following the administration of 10 mg oral daily doses. Profile on the left side represents atrasentan administered alone while the profile on the right side is concurrent with docetaxel administration on Cycle 2. Each point represents the average concentration of all patients and the shaded band represents the standard deviation.